Jaguar Health (JAGX) Gross Profit (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Gross Profit data on file, last reported at $19.1 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 1025.01% year-over-year to $19.1 million in Q1 2026; TTM through Mar 2026 was $25.2 million, a 164.42% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, down 20.52% from the prior year.
• Gross Profit for Q1 2026 stood at $19.1 million, up from $1.0 million in the prior quarter.
• Over the last five years, Gross Profit for JAGX reached as high as $19.1 million in Q1 2026 and fell as low as -$463000.0 in Q4 2022.
• Historically, Gross Profit has averaged $2.7 million across 5 years, with a median of $2.3 million in 2024.
• On a YoY basis, Gross Profit climbed as much as 126100.0% in 2022 and fell as far as 169.6% in 2022.
• Year by year, Gross Profit stood at -$463000.0 in 2022, then soared by 448.38% to $1.6 million in 2023, then soared by 83.01% to $3.0 million in 2024, then slumped by 64.94% to $1.0 million in 2025, then jumped by 1746.76% to $19.1 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $19.1 million in Q1 2026, $1.0 million in Q4 2025, and $2.6 million in Q3 2025.